Mylan, Fujifilm Kyowa Kirin Receive FDA Approval Of Hulio - Quick Facts

Pharmaceutical companies Mylan N.V. (MYL) and Fujifilm Kyowa Kirin Biologics Co., Ltd. announced Thursday that the U.S. Food and Drug Administration (FDA) has approved Hulio (adalimumab-fkjp), a biosimilar to AbbVie's Humira (adalimumab). This will help bring another affordable treatment option to U.S. patients living with chronic inflammatory conditions.

from RTT - Biotech https://ift.tt/31Y73Rk
via IFTTT